1. Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
    Giorgiana Negrea et al, 2022, Frontiers in Pharmacology CrossRef
  2. Targeting of M2 macrophages with IL-13-functionalized liposomal prednisolone inhibits melanoma angiogenesis in vivo
    Alina Sesarman et al, 2024, Journal of Liposome Research CrossRef
  3. Tumor-associated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stress-dependent manner
    Lavinia Luput et al, 2017, Oncology Reports CrossRef
  4. Biologically Active Ajuga Species Extracts Modulate Supportive Processes for Cancer Cell Development
    Valentin-Florian Rauca et al, 2019, Frontiers in Pharmacology CrossRef
  5. Combination therapy of simvastatin and 5, 6-dimethylxanthenone-4-acetic acid synergistically suppresses the aggressiveness of B16.F10 melanoma cells
    Valentin-Florian Rauca et al, 2018, PLOS ONE CrossRef
  6. Normoxic Tumour Extracellular Vesicles Modulate the Response of Hypoxic Cancer and Stromal Cells to Doxorubicin In Vitro
    Laura Patras et al, 2020, International Journal of Molecular Sciences CrossRef
  7. Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer
    Lucia Ruxandra Tefas et al, 2023, Journal of Liposome Research CrossRef
  8. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinomain vivo
    Laura Patras et al, 2017, Cancer Biology & Therapy CrossRef
  9. A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy
    Elena De Mattia et al, 2018, Frontiers in Pharmacology CrossRef
  10. The novel gene HA117 promotes in vitro and in vivo drug resistance in mouse colon tumor cells
    Y X Guo et al, 2017, Cancer Gene Therapy CrossRef
  11. Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells
    Alina Sesarman et al, 2018, Pharmacological Reports CrossRef
  12. Macrophages induce “budding” in aggressive human colon cancer subtypes by protease-mediated disruption of tight junctions
    Kari Trumpi et al, 2018, Oncotarget CrossRef
  13. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition
    Chinmayee Sethy et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  14. Liposomal simvastatin sensitizes C26 murine colon carcinoma to the antitumor effects of liposomal 5‐fluorouracil in vivo
    Lavinia Luput et al, 2020, Cancer Science CrossRef

  15. HLJ2 Effectively Ameliorates Colitis-Associated Cancer via Inhibition of NF-κB and Epithelial–Mesenchymal Transition


    Huachen Song et al, 2020, Drug Design, Development and Therapy CrossRef
  16. Intensive therapy with gastropodan hemocyanins increases their antitumor properties in murine model of colon carcinoma
    Emiliya Stoyanova et al, 2020, International Immunopharmacology CrossRef